Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 970

1.

Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.

Morley SL, Cole MJ, Ison CA, Camaraza MA, Sotolongo F, Anwar N, Cuevas I, Carbonero M, Campa HC, Sierra G, Levin M.

Pediatr Infect Dis J. 2001 Nov;20(11):1054-61.

PMID:
11734711
[PubMed - indexed for MEDLINE]
2.

Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.

Tappero JW, Lagos R, Ballesteros AM, Plikaytis B, Williams D, Dykes J, Gheesling LL, Carlone GM, Høiby EA, Holst J, Nøkleby H, Rosenqvist E, Sierra G, Campa C, Sotolongo F, Vega J, Garcia J, Herrera P, Poolman JT, Perkins BA.

JAMA. 1999 Apr 28;281(16):1520-7.

PMID:
10227322
[PubMed - indexed for MEDLINE]
3.

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial.

MacLennan JM, Shackley F, Heath PT, Deeks JJ, Flamank C, Herbert M, Griffiths H, Hatzmann E, Goilav C, Moxon ER.

JAMA. 2000 Jun 7;283(21):2795-801.

PMID:
10838647
[PubMed - indexed for MEDLINE]
4.

Phase II meningococcal B vesicle vaccine trial in New Zealand infants.

Jackson C, Lennon DR, Sotutu VT, Yan J, Stewart JM, Reid S, Crengle S, Oster P, Ypma E, Aaberge I, Mulholland K, Martin DR.

Arch Dis Child. 2009 Oct;94(10):745-51. doi: 10.1136/adc.2007.132571. Epub 2008 Oct 6.

PMID:
18838420
[PubMed - indexed for MEDLINE]
5.

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease.

Holst J, Feiring B, Fuglesang JE, Høiby EA, Nøkleby H, Aaberge IS, Rosenqvist E.

Vaccine. 2003 Jan 30;21(7-8):734-7.

PMID:
12531351
[PubMed - indexed for MEDLINE]
6.

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

Noronha CP, Struchiner CJ, Halloran ME.

Int J Epidemiol. 1995 Oct;24(5):1050-7.

PMID:
8557439
[PubMed - indexed for MEDLINE]
7.

Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.

Toropainen M, Saarinen L, Wedege E, Bolstad K, Mäkelä PH, Käyhty H.

Vaccine. 2005 Sep 23;23(40):4821-33.

PMID:
15970361
[PubMed - indexed for MEDLINE]
8.

Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents.

Boutriau D, Poolman J, Borrow R, Findlow J, Domingo JD, Puig-Barbera J, Baldó JM, Planelles V, Jubert A, Colomer J, Gil A, Levie K, Kervyn AD, Weynants V, Dominguez F, Barberá R, Sotolongo F.

Clin Vaccine Immunol. 2007 Jan;14(1):65-73. Epub 2006 Oct 25.

PMID:
17065257
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

Gorringe AR, Taylor S, Brookes C, Matheson M, Finney M, Kerr M, Hudson M, Findlow J, Borrow R, Andrews N, Kafatos G, Evans CM, Read RC.

Clin Vaccine Immunol. 2009 Aug;16(8):1113-20. doi: 10.1128/CVI.00118-09. Epub 2009 Jun 24.

PMID:
19553555
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children.

McVernon J, Maclennan J, Buttery J, Oster P, Danzig L, Moxon ER.

Pediatr Infect Dis J. 2002 Aug;21(8):747-53.

PMID:
12192163
[PubMed - indexed for MEDLINE]
11.

Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay.

Ison CA, Anwar N, Cole MJ, Galassini R, Heyderman RS, Klein NJ, West J, Pollard AJ, Morley S, Levin and the Meningococcal Re.

Microb Pathog. 1999 Oct;27(4):207-14.

PMID:
10502461
[PubMed - indexed for MEDLINE]
12.

New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.

Wong S, Lennon D, Jackson C, Stewart J, Reid S, Crengle S, Tilman S, Aaberge I, O'Hallahan J, Oster P, Mulholland K, Martin D.

Pediatr Infect Dis J. 2007 Apr;26(4):345-50.

PMID:
17414400
[PubMed - indexed for MEDLINE]
13.

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger K, Blatter MM, Quataert SA, Madore DV, Chang I, Malinoski FJ, Hackell JG, Paradiso PR.

Pediatr Infect Dis J. 2001 Feb;20(2):153-9.

PMID:
11224833
[PubMed - indexed for MEDLINE]
14.

Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.

Rennels M, King J Jr, Ryall R, Papa T, Froeschle J.

Pediatr Infect Dis J. 2004 May;23(5):429-35.

PMID:
15131466
[PubMed - indexed for MEDLINE]
15.

Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.

Fischer M, Carlone GM, Holst J, Williams D, Stephens DS, Perkins BA.

Vaccine. 1999 May 14;17(19):2377-83.

PMID:
10392619
[PubMed - indexed for MEDLINE]
16.

Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine.

Wong SH, Lennon DR, Jackson CM, Stewart JM, Reid S, Ypma E, O'Hallahan JM, Oster P, Mulholland K, Martin DR.

Pediatr Infect Dis J. 2009 May;28(5):385-90. doi: 10.1097/INF.0b013e318195205e.

PMID:
19384263
[PubMed - indexed for MEDLINE]
17.

Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.

Naess LM, Aarvak T, Aase A, Oftung F, Høiby EA, Sandin R, Michaelsen TE.

Vaccine. 1999 Feb 26;17(7-8):754-64.

PMID:
10067680
[PubMed - indexed for MEDLINE]
18.

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.

Campagne G, Garba A, Fabre P, Schuchat A, Ryall R, Boulanger D, Bybel M, Carlone G, Briantais P, Ivanoff B, Xerri B, Chippaux JP.

Pediatr Infect Dis J. 2000 Feb;19(2):144-50.

PMID:
10694002
[PubMed - indexed for MEDLINE]
19.

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.

Perrett KP, Snape MD, Ford KJ, John TM, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ.

Pediatr Infect Dis J. 2009 Mar;28(3):186-93. doi: 10.1097/INF.0b013e31818e037d.

PMID:
19209097
[PubMed - indexed for MEDLINE]
20.

Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy.

Milagres LG, Ramos SR, Sacchi CT, Melles CE, Vieira VS, Sato H, Brito GS, Moraes JC, Frasch CE.

Infect Immun. 1994 Oct;62(10):4419-24.

PMID:
7927704
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk